skip to Main Content

What is Semaglutide?

Semaglutide can help control your cravings, blood sugar regulation, and appetite to achieve significant weight loss! Semaglutide is an FDA-approved prescription for weight management.

  • Semaglutide is a weight loss medication received by weekly injection
  • Semaglutide is FDA-approved for weight loss
  • Semaglutide is more effective than all prior weight loss medications!

How Does Semaglutide Work?

  • Slows down stomach emptying so that after eating, you feel full longer
  • Suppresses appetite and food cravings (on average, patients eat ~30% less)
  • Lowers blood glucose levels (without making glucose levels too low)

Your body naturally produces several substances that affect your appetite. One of these is called glucagon-like peptide-1 (GLP-1). The body produces GLP-1 naturally when you eat. GLP-1 stops you from feeling hungry and makes you feel full or satisfied.

Semaglutide imitates GLP-1 in the body. This means that Semaglutide provides the same effect as this natural substance (GLP-1) in our bodies.

Reduced food intake: Because Semaglutide reduces feelings of hunger, you eat less food. When combined with a healthy diet, exercise, and everything @Chill Cryotherapy, Semaglutide will help you lose weight!

Effect on plaques in your blood vessels: In animal studies, Semaglutide stopped the progression of plaque formation in blood vessels. This is likely why Semaglutide has also been shown to reduce the risk of cardiovascular events and strokes.

Who Can Take Semaglutide?

Adult and teenage patients who are looking to lose weight! Semaglutide is FDA-approved for adults & teenagers with a BMI of 27 or above,

Our physicians and nurse practitioners will evaluate you and determine if Semaglutide can help you lose weight to live a healthier life!

Semaglutide is extremely effective in helping obese and overweight patients lose weight. It is safe for individuals with hypertension, type-2 diabetes, and dyslipidemia.

Who Cannot Take Semaglutide?

You CAN NOT take Semaglutide if you have any of the following conditions:

  • personal or family history of Medullary Thyroid Carcinoma (MTC)
  • personal or family history of Multiple Endocrine Neoplasia, type 2 (MEN 2)
  • prior allergic reaction to Semaglutide or to any of its ingredients*
  • diabetic retinopathy (diabetic eye disease)
  • pregnant or trying to get pregnant
  • breast-feeding (Semaglutide is present in breast milk)
  • depression with a history of suicidal thoughts
  • history of pancreatitis
  • kidney disease/kidney insufficiency
  • stomach problems
  • diabetes—you must obtain approval for use from endocrinology or primary care physician)

What Are the Ingredients in Semaglutide?

Active Ingredient: Semaglutide and Vitamin B12 (cyanocobalamin)

We include vitamin B12 with our Semaglutide injections in order to reduce the incidence of nausea or stomach upset.

Get Started Today

Step 1.

Purchase your physician consultation. You can add that to the cart using this button.
Also, complete and sign both the General Consent Form and the Semaglutide and Tirzepatide Consent Forms.

Step 2.

Add your Semaglutide treatments to the cart (Month 1 at a minimum is required)

You can purchase up to 5 months individually. The price per month varies based on the dosage. You must purchase them in the sequence offered 1, 2, 3, 4, 5.

We also offer a bundle for months 1 - 3, where you can save $100.

Frequently Asked Questions


We offer several options:

  • Initial Physician Consult $100 (Required)
  • Semaglutide .25 mg/.05 ml Month 1: $350
  • Semaglutide .5 mg / .1 ml Month 2: $299
  • Semaglutide 1 mg / .2 ml Month 3: $349
  • Semaglutide 1.7 mg / .34 ml Month 4: $399
  • Semaglutide 2.4 mg / .48 ml Month 5: $499
  • Semaglutide 3 Month Bundle Monoths 1 - 3: $898 (Savings of $100)

Follow-up consultation with physician or physician extender if required: $99.

Please complete the General Consent Form and the Semaglutide and Tirzepatide Consent Form before treatment.

Research Articles and Clinical Trials

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial

Impact of Semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials

FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014

Back To Top